Psoriatic arthritis (psa) treatment market by Monica

Psoriatic Arthritis (PsA) Treatment Market: Global Industry Analysis and Opportunity Assessment 20172027 February 2017

About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client.

Research Capabilities    

Customized Research Syndicated Research Investment Research

Social Media Research

Customized Research Syndicated Research Investment Research Social Media Research

Sector Coverage    

Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment

   

Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

Research Methodology (1/2) Systematic Research Approach 1 Market profiling

2 Formulating discussion guide

3 Developing list of respondents

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. PMR formulates a detailed discussion guide to conduct expert and industry interviews PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts

Data collection

PMR conducts interviews with industry experts, industry players, distributors and retailers

Data validation

Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data

5 6

Data analysis

Insights

Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry PMR delivers industry insights and information in the required format (PDF)

Data Collection

   

Research & Intelligence

Data Filter & Analysis

Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain

Actionable Insights

A Primary Research

     

B SOLUTION     

Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments

Primary Research #    

Linkedin Zoominfo Salesforce Avention

Business Solution

Desk Research

Key industry experts Channel study Developments Market dynamics Products Conclusions

Company Analysis

Secondary Research #    

Company websites Company annual reports White papers Financial reports

Paid Publications#    

Factiva GBI Genios Meltwater

# includes sources of databases

Psoriatic Arthritis (PsA) Treatment Market Psoriatic arthritis (PsA) is an inflammatory condition that causes inflammation of joints. Psoriatic arthritis affects both the skin and the musculoskeletal system. Musculoskeletal symptoms include joint pain, swelling, tenderness, morning stiffness, reduction in joint movement; skin symptoms include reddening and thickness of the skin, separation on the nail bed; other symptoms include general fatigue, inflammation of the membrane lining the eyelid Psoriatic arthritis mainly affect those who are affected with skin disease known as psoriasis. Out of 10 people with psoriasis, only one or two will develop arthritis. Psoriasis is characterized by scaly red and white skin patches that may affect any joint in the body such as elbows, knees, scalp, including the spine and others. Psoriatic arthritis is caused due to genetic and environmental factors. It often, often between the ages of 30 and 50 years, but it can also develop in children called psoriatic type juvenile idiopathic arthritis. It is more common in Caucasians people than African Americans or Asian. According to disease control and prevention, about five to seven percent of the population suffer from psoriasis, out of these 10-20% people will develop psoriatic arthritis. Diagnosis of the psoriatic arthritis is done by rheumatologists, by looking at the swollen and painful joints, skin and nail change by various diagnostic procedures like X-rays, MRI, ultrasound, CT scans and others Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-2718 Treatment for psoriatic arthritis depends on its severity. Various over-the-counter (OTC) drugs and prescribed drugs are available for treatment. Drugs prescribed for psoriatic arthritis includes immunesuppressing drugs, Non-steroidal drugs, and various biologics. Biologics works by stopping the inflammatory process, mainly tumor necrosis factor (TNF) and interleukin (IL) inhibitors are used to treat psoriatic arthritis. ÂŠ2015 Future Market Insights, All Rights Reserved

Psoriatic Arthritis (PsA) Treatment Market Different ways for the treatment include Short-term oral therapy, Low-dose, ongoing oral therapy or Injection administered directly into the joint. Change on lifestyle such as physical exercise, limiting alcohol intake, weight management etc. may also help in the treatment process. Psoriasis is a severe disease affecting about 100 million individuals globally, according to world health organization prevalence of psoriasis in countries ranges 0.09% to 11.43%. Patient with psoriasis is at higher risk of developing other clinical conditions such as CVD and other non-communicable diseases. The global psoriatic arthritis (PsA) treatment market is segmented on basis of mechanism of action, disease condition, distribution channel and geography. Global psoriatic arthritis (PsA) treatment market is segmented by mechanism of action, disease condition and distribution channel. Based on the product type, global psoriatic arthritis (PsA) treatment market is segmented TNF inhibitors, PDE4 inhibitors, and Interleukin blockers. TNF-Îą inhibitors are said to revolutionize the market. IL-17 inhibitors are the latest wave, as companies are developing new biologics based on this inhibitor. On the basis of disease condition, the global psoriatic arthritis (PsA) treatment market is segmented into mild psoriatic arthritis, moderate psoriatic arthritis and severe psoriatic arthritis. On the basis of distribution channel, the global psoriatic arthritis (PsA) treatment market is segmented into hospital pharmacy, drug stores, retail pharmacy and e-commerce. Rise in incidence of psoriatic arthritis, increased awareness of healthcare professional and new product launch is said to drive the global psoriatic arthritis (PsA) treatment market during the forecast period. Whereas inadequate access to health care, cost and availability of essential medicines and lack of standardized tools for diagnosis and treatment will hamper the growth of global psoriatic arthritis (PsA) treatment market. Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-2718 ÂŠ2015 Future Market Insights, All Rights Reserved

Psoriatic Arthritis (PsA) Treatment Market By regional presence, the global psoriatic arthritis (PsA) treatment market is segmented into five broad regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America is estimated to lead the global psoriatic arthritis (PsA) treatment market. According to world health organization, in 2008, the annual cost of psoriasis in the United States was estimated at US$ 11.5 billion. Europe market is also projected to experience high growth in the near future. Asia Pacific market is anticipated to grow at the fastest growth rate during the forecast period, owing to factors such as rising standard of living, lifestyle changes and focusing on healthcare expenditures. Some of the major players in global psoriatic arthritis (PsA) treatment market are Celgene Corporation, Amgen Inc., AbbVie, F. Hoffmann-La Roche AG, Janssen Global Services, LLC, Eli Lilly and Company, UCB, Inc., Bristol-Myers Squibb Company, Novartis AG and Others.

Browse Full Report@ http://www.futuremarketinsights.com/reports/psoriatic-arthritis-psa-treatmentmarket

To know more about us, please visit our website:

www.futuremarketinsights.com For sales queries or new topics email us on:

sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

Thank You Future Market Insights Global & Consulting Private Limited (FMI)